Saade Rami, Jabbour Caroline, Keyrouz Elias, Hassan Jana, Baba Bassel El, Hajj Anita El, Ghanem Hady
Department of Otolaryngology Head & Neck Surgery, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University Medical Center, Beirut, Lebanon.
Radiation Oncology, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University Medical Center, Beirut, Lebanon.
Eur Arch Otorhinolaryngol. 2025 Sep 18. doi: 10.1007/s00405-025-09647-8.
Laryngeal cancer is a major malignancy in head and neck oncology, with total laryngectomy (TL) as a key intervention for advanced and recurrent disease. This systematic review and meta-analysis compare primary total laryngectomy (PTL) and salvage total laryngectomy (STL) in survival, functional outcomes, and complications.
A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was conducted up to January 18, 2025. Studies comparing PTL and STL were included based on predefined eligibility criteria. Data extraction and quality assessment were performed independently by two reviewers. Random-effects models were used to calculate pooled odds ratios (ORs) and mean differences (MDs), with heterogeneity assessed via I² statistics. Sensitivity analyses ensured result robustness.
Thirteen studies (2,704 patients: 913 STL, 1,791 PTL) met inclusion criteria. PTL showed significantly higher overall survival at 1 year (OR = 2.21; 95% CI: 1.38-3.55), 2 years (OR = 1.95; 95% CI: 1.40-2.71), and 3 years (OR = 1.64; 95% CI: 1.10-2.47). STL had higher risks of pharyngocutaneous fistula (OR = 2.78; 95% CI: 1.96-3.95) and reconstructive surgery (OR = 0.11; 95% CI: 0.02-0.75). PTL significantly reduced swallowing difficulty (OR = 0.12; 95% CI: 0.05-0.28) and hypopharyngeal stricture (OR = 0.14; 95% CI: 0.04-0.49). Speech functional outcomes showed no significant differences.
PTL improves survival and swallowing function with fewer complications, making it a preferred upfront treatment. STL remains essential for managing failures. Early identification of high-risk patients may improve clinical decision-making, optimizing survival and functional outcomes.
喉癌是头颈肿瘤学中的一种主要恶性肿瘤,全喉切除术(TL)是晚期和复发性疾病的关键干预措施。本系统评价和荟萃分析比较了初次全喉切除术(PTL)和挽救性全喉切除术(STL)在生存率、功能结局和并发症方面的差异。
截至2025年1月18日,对PubMed、Scopus、Web of Science和谷歌学术进行了全面检索。根据预先确定的纳入标准纳入比较PTL和STL的研究。由两名 reviewers 独立进行数据提取和质量评估。采用随机效应模型计算合并比值比(OR)和平均差(MD),通过I²统计量评估异质性。敏感性分析确保结果的稳健性。
13项研究(2704例患者:913例STL,1791例PTL)符合纳入标准。PTL在1年(OR = 2.21;95%CI:1.38 - 3.55)、2年(OR = 1.95;95%CI:1.40 - 2.71)和3年(OR = 1.64;95%CI:1.10 - 2.47)时的总生存率显著更高。STL发生咽皮肤瘘(OR = 2.78;95%CI:1.96 - 3.95)和重建手术(OR = 0.11;95%CI:0.02 - 0.75)的风险更高。PTL显著降低了吞咽困难(OR = 0.12;95%CI:0.05 - 0.28)和下咽狭窄(OR = 0.14;95%CI:0.04 - 0.49)的发生率。言语功能结局无显著差异。
PTL可提高生存率和吞咽功能,并发症更少,使其成为首选的前期治疗方法。STL对于处理治疗失败情况仍然至关重要。早期识别高危患者可能改善临床决策,优化生存和功能结局。